Regression methods for cost-effectiveness analysis with censored data

A.R. Willan; D.Y. Lin; A. Manca

doi:10.1002/sim.1794

Regression methods for cost-effectiveness analysis with censored data

A.R. Willan, D.Y. Lin, A. Manca

Centre for Health Economics

Research output: Contribution to journal › Article › peer-review

Abstract

A system of seemingly unrelated regression equations is proposed for prognostic factor adjustment and subgroup analysis when comparing two groups in a cost-effectiveness analysis with censored data. Because of the induced dependent censoring on costs and quality-adjusted survival, inverse probability weighting is employed for parameter estimation. The method is illustrated with data from two recent examples using both survival time and quality-adjusted survival time as the measures of effectiveness. Copyright (C) 2004 John Wiley Sons, Ltd.

Original language	English
Pages (from-to)	131-145
Number of pages	15
Journal	Statistics in Medicine
Volume	24
Issue number	1
DOIs	https://doi.org/10.1002/sim.1794
Publication status	Published - 15 Jan 2005

Keywords

regression
censored data
cost-effectiveness
incremental net benefit
inverse probability weighting
QUALITY-ADJUSTED SURVIVAL
IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
RANDOMIZED CLINICAL-TRIALS
ESTIMATING MEDICAL COSTS
INCREMENTAL NET BENEFIT
CONFIDENCE-INTERVALS
EFFECTIVENESS RATIOS
HEALTH
TIME
HYSTERECTOMY

Access to Document

10.1002/sim.1794

http://dx.doi.org/10.1002/sim.1794

Cite this

@article{d03ebf66e1ec4cc6a586bb983ccd965b,

title = "Regression methods for cost-effectiveness analysis with censored data",

abstract = "A system of seemingly unrelated regression equations is proposed for prognostic factor adjustment and subgroup analysis when comparing two groups in a cost-effectiveness analysis with censored data. Because of the induced dependent censoring on costs and quality-adjusted survival, inverse probability weighting is employed for parameter estimation. The method is illustrated with data from two recent examples using both survival time and quality-adjusted survival time as the measures of effectiveness. Copyright (C) 2004 John Wiley Sons, Ltd.",

keywords = "regression, censored data, cost-effectiveness, incremental net benefit, inverse probability weighting, QUALITY-ADJUSTED SURVIVAL, IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR, RANDOMIZED CLINICAL-TRIALS, ESTIMATING MEDICAL COSTS, INCREMENTAL NET BENEFIT, CONFIDENCE-INTERVALS, EFFECTIVENESS RATIOS, HEALTH, TIME, HYSTERECTOMY",

author = "A.R. Willan and D.Y. Lin and A. Manca",

year = "2005",

month = jan,

day = "15",

doi = "10.1002/sim.1794",

language = "English",

volume = "24",

pages = "131--145",

journal = "Statistics in Medicine",

issn = "0277-6715",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Regression methods for cost-effectiveness analysis with censored data

AU - Willan, A.R.

AU - Lin, D.Y.

AU - Manca, A.

PY - 2005/1/15

Y1 - 2005/1/15

N2 - A system of seemingly unrelated regression equations is proposed for prognostic factor adjustment and subgroup analysis when comparing two groups in a cost-effectiveness analysis with censored data. Because of the induced dependent censoring on costs and quality-adjusted survival, inverse probability weighting is employed for parameter estimation. The method is illustrated with data from two recent examples using both survival time and quality-adjusted survival time as the measures of effectiveness. Copyright (C) 2004 John Wiley Sons, Ltd.

AB - A system of seemingly unrelated regression equations is proposed for prognostic factor adjustment and subgroup analysis when comparing two groups in a cost-effectiveness analysis with censored data. Because of the induced dependent censoring on costs and quality-adjusted survival, inverse probability weighting is employed for parameter estimation. The method is illustrated with data from two recent examples using both survival time and quality-adjusted survival time as the measures of effectiveness. Copyright (C) 2004 John Wiley Sons, Ltd.

KW - regression

KW - censored data

KW - cost-effectiveness

KW - incremental net benefit

KW - inverse probability weighting

KW - QUALITY-ADJUSTED SURVIVAL

KW - IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR

KW - RANDOMIZED CLINICAL-TRIALS

KW - ESTIMATING MEDICAL COSTS

KW - INCREMENTAL NET BENEFIT

KW - CONFIDENCE-INTERVALS

KW - EFFECTIVENESS RATIOS

KW - HEALTH

KW - TIME

KW - HYSTERECTOMY

U2 - 10.1002/sim.1794

DO - 10.1002/sim.1794

M3 - Article

SN - 0277-6715

VL - 24

SP - 131

EP - 145

JO - Statistics in Medicine

JF - Statistics in Medicine

IS - 1

ER -